VLON Market Cap History Table | ||||||||||||||||||||||
Also see: VLON Shares Outstanding History and VLON YTD Return |
VLON Market Cap History Table | ||||||||||||||||||||||
Also see: VLON Shares Outstanding History and VLON YTD Return |
VLON Market Cap History Chart | ||||||||||||||||||||||||||||||
-51.57% CAGR Mouse over chart for data details
|
VLON Stock Price Chart |
About GRI Bio Inc |
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company primarily focused on the development and commercialization of biopharmaceutical products. Co. is developing medications for central nervous system disorders with a focus on abuse-deterrent medications. Co.'s primary investigational product candidate, ADAIR, is a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine (the main active ingredient in Adderall®) for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. ADAIR is designed to deter attempts to crush and snort and to provide barriers to injection while still providing the therapeutic benefit when taken orally. We show 10 historical shares outstanding datapoints in our VLON shares outstanding history coverage, used to compute VLON market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VLON market cap history over the course of time is important for investors interested in comparing VLON's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VLON versus a peer is one thing; comparing VLON market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VLON can fluctuate over the course of history. With this page we aim to empower investors researching VLON by allowing them to research the VLON market cap history. |
VLON Current Stock Quote |
Free VLON Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
VLON Share Performance |
Market Cap Peers |
Vallon Pharmaceuticals (VLON) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VLRX Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.